Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DYN | IMAX |
|---|---|---|
| Price | $15.44 | $52.58 |
| Change today | ▲ 1.58% | ▼ 0.27% |
| Market cap | $2.88B | $2.88B |
| Return, 3 months | -35.2% | +40.3% |
| Return, year to date | -21.1% | +42.3% |
| Return, 1 year | +22.1% | +57.7% |
| P/E (TTM) | -4.7 | 72.0 |
| P/B | 4.1 | 8.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | -61.1% | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +124.5% | -1.4% |
| Analyst buy share | 93% | 78% |
| RSI (14) | 24 | 48 |
| 30-day volatility | 62.5% | 30.7% |
| Max drawdown, 1 year | -43.2% | -22.7% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
